# Bortezomib

NDC: 51817-586
Generic name: bortezomib
Labeler / Manufacturer: Pharmascience Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20220502

FDA application: ANDA208392

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51817-586"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51817-586
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=191d231a-1fbd-4a65-9d33-d5dc03bac381